ArticleGlobal health, science and practice2020
What Makes a National Pharmaceutical Track and Trace System Succeed? Lessons From Turkey.
Article in Global health, science and practice, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Local systems, local solutions: which factors drive essential medicine availability in public health facilities across Indonesia?BMJ global health · 2026Article
- Factors contributing to human and veterinary medicine shortages in developing countries: perspectives of suppliers and regulators in Namibia.Tropical medicine and health · 2025Article
- Article
- Managing medicines in decentralization: discrepancies between national policies and local practices in primary healthcare settings in Indonesia.Health policy and planning · 2025Article
- Making intersectoral stakeholder engagement in medicine quality research work: lessons from the STARmeds study in Indonesia.Health research policy and systems · 2025Article
- The challenges associated with the prevention of smuggling and counterfeiting health goods in Iran.BMC public health · 2024Article
- The availability of essential medicines in primary health centres in Indonesia: achievements and challenges across the archipelago.The Lancet regional health. Southeast Asia · 2024Article
- Pharmacy practice and policy research in Türkiye: a systematic review of literature.Journal of pharmaceutical policy and practice · 2024Review
- Why falsified medicines reach patients: an analysis of political and economic factors in Romania.BMJ global health · 2023Review
- Implementing pharmaceutical track-and-trace systems: a realist review.BMJ global health · 2021Article
- Tackling the global impact of substandard and falsified and unregistered/unlicensed anti-tuberculosis medicines.The journal of medicine accessArticle
- Substandard and falsified medical product recalls in Zambia from 2018 to 2021 and implications on the quality surveillance systems.The journal of medicine accessArticle
- Assessing the performance of local pharmaceutical systems: An analytical approach to improve access to medicine.The journal of medicine accessReview
- Medicine quality in high-income countries: The obstacles to comparative prevalence studies.Medicine access @ point of careArticle
Corrections and comments
- Erratum issued
Authors and funding
3 authors.
Funding
Abstract
backgroundTrack and trace systems are increasingly being implemented as a technological solution to secure pharmaceutical supply chains. Turkey was the first country to implement a full pharmaceutical track and trace system throughout the entire regulated domestic supply chain. This article explores the emergence and functioning of this system and the consequences for substandard and falsified medicine with a focus on the underlying political and economic factors.
methodsThis study uses an explanatory case study approach that combined interviews with purposefully selected key informants and document analyses.
resultsThe main drivers for implementing the pharmaceutical track and trace system in Turkey centered on the elimination of reimbursement fraud and the prevention of falsified medicine in the regulated supply chain. Although stakeholders experienced both physical and software-related problems in implementation, the alignment of incentives of all stakeholders with the power of the state, along with leeway for adaptations, ultimately resulted in a successful process. This track and trace system provides a clean regulated supply chain, minimizes reimbursement fraud, facilitates fast market recalls, and can flag likely medicine shortages. Staff previously engaged in pharmacy inspections now concentrate on ensuring production quality, which reduces the risk of substandard medicines.
conclusionsIn Turkey, 4 factors drove the successful implementation of pharmaceutical track and trace: the political determination to eliminate reimbursement fraud, a large pharmaceutical market dominated by a single payer, medicine reimbursement being contingent on verified dispensing and prescription, and flexibility to adapt the system according to the needs of stakeholders during implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.